1240
茂生農經
0.00 (0.00%)55.203成交張數10.26本益比1.63股價淨值比0.91%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入20252,744年增 -4.0%
毛利率202514.3%最新一期
營業利益率20254.8%最新一期
每股盈餘20254.86年增 +12.0%
| 會計項目 | 走勢 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 銷貨收入 | – | – | – | – | – | -13.7% | -1.8% | -4.0% | |
| 銷貨收入淨額 | – | +22.2% | +25.2% | +31.7% | +12.4% | -13.7% | -1.8% | -4.0% | |
| 營業收入合計 | – | +22.2% | +25.2% | +31.7% | +12.4% | -13.7% | -1.8% | -4.0% | |
| 銷貨成本 | – | +17.6% | +29.2% | +36.6% | +13.6% | -16.1% | -3.2% | -4.4% | |
| 營業成本合計 | – | +17.6% | +29.2% | +36.6% | +13.6% | -16.1% | -3.2% | -4.4% | |
| 原始認列生物資產及農產品之利益(損失) | – | – | – | -82.0% | -387.5% | – | +190.1% | -58.5% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | +735.7% | -4.6% | -57.1% | +54.8% | +15.6% | +14.5% | |
| 營業毛利（毛損） | – | +60.0% | +27.3% | -5.9% | -13.7% | +24.7% | +15.0% | -1.8% | |
| 營業毛利（毛損）淨額 | – | +60.0% | +27.3% | -5.9% | -13.7% | +24.7% | +15.0% | -1.8% | |
| 推銷費用 | – | +35.6% | +36.3% | +44.5% | +14.8% | -23.2% | +10.9% | +4.9% | |
| 管理費用 | – | +79.9% | +34.3% | -14.1% | -15.4% | +28.2% | +5.0% | -3.4% | |
| 研究發展費用 | – | +134.1% | +30.8% | -69.3% | -15.5% | -16.2% | +51.2% | +8.7% | |
| 預期信用減損損失（利益） | – | +760.5% | -145.6% | – | – | -152.9% | – | +815.3% | |
| 營業費用合計 | – | +65.1% | +24.2% | +12.4% | +7.3% | -11.9% | +10.7% | +5.7% | |
| 營業利益（損失） | – | +52.1% | +32.5% | -34.3% | -69.5% | +367.7% | +22.6% | -13.7% | |
| 利息收入 | – | – | – | -35.1% | +10.3% | +747.5% | +201.9% | +9.9% | |
| 其他收入 | – | -13.5% | +3.3% | +2.0% | +13.9% | -10.1% | +5.6% | +2.9% | |
| 其他利益及損失淨額 | – | – | +77.6% | +31.3% | -367.5% | – | -158.9% | – | |
| 財務成本淨額 | – | -23.0% | +0.1% | -12.0% | +145.2% | +25.4% | -13.4% | -16.7% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | +27.7% | -30.8% | -8.8% | -131.6% | – | +24.9% | +44.8% | |
| 營業外收入及支出合計 | – | +43.5% | -19.1% | -0.4% | -162.4% | – | +10.1% | +79.2% | |
| 稅前淨利（淨損） | – | +48.6% | +12.2% | -24.7% | -104.4% | – | +19.2% | +9.8% | |
| 所得稅費用（利益）合計 | – | +148.6% | +35.5% | -23.0% | -59.3% | +185.8% | +6.9% | -56.6% | |
| 繼續營業單位本期淨利（淨損） | – | +36.5% | +7.1% | -25.2% | -117.4% | – | +22.5% | +25.4% | |
| 本期淨利（淨損） | – | +36.5% | +7.1% | -25.2% | -117.4% | – | +22.5% | +25.4% | |
| 確定福利計畫之再衡量數 | – | +107.7% | +54.3% | -53.9% | +252.8% | -71.4% | +320.9% | -10.3% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | -438.6% | – | +461.2% | -67.2% | -105.3% | – | – | |
| 與不重分類之項目相關之所得稅 | – | – | +54.6% | -53.9% | +252.7% | -71.4% | +321.9% | -10.3% | |
| 不重分類至損益之項目： | – | – | – | +385.1% | -62.7% | -100.8% | – | – | |
| 其他綜合損益（淨額） | – | -430.2% | – | +385.1% | -62.7% | -100.8% | – | – | |
| 本期綜合損益總額 | – | -161.0% | – | +16.4% | -94.3% | – | +22.2% | -1.9% | |
| 母公司業主（淨利∕損） | – | – | +14.0% | -15.6% | -95.7% | – | +10.7% | +19.7% | |
| 非控制權益（淨利∕損） | – | – | – | – | – | – | – | – | |
| 母公司業主（綜合損益） | – | – | – | +22.8% | -83.2% | +357.8% | +10.4% | -5.7% | |
| 非控制權益（綜合損益） | – | – | – | – | – | – | – | – | |
| 基本每股盈餘 | – | +25.3% | +10.7% | -19.6% | -96.1% | – | +5.3% | +12.0% | |
| 繼續營業單位淨利（淨損） | – | +25.4% | +10.5% | -19.7% | -96.1% | – | +5.4% | +11.8% | |
| 稀釋每股盈餘 | – | +25.4% | +10.5% | -19.7% | -96.1% | – | +5.4% | +11.8% | |
| 原始認列生物資產及農產品之利益（損失） | – | – | – | – | – | – | – | – | |
| 生物資產當期公允價值減出售成本之變動利益（損失） | – | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。